• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌中的天然产物与长链非编码RNA:新兴治疗方法

Natural Products and lncRNAs in Renal Cell Carcinoma: Emerging Therapeutic Approaches.

作者信息

Doghish Ahmed S, Abd-Elmawla Mai A, Aborehab Nora M, Radwan Abdullah F, Ghaiad Heba R, Nassar Khloud, Mohammed Osama A, Elimam Hanan

机构信息

Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Cairo, Egypt.

Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.

出版信息

J Gene Med. 2025 Jun;27(6):e70026. doi: 10.1002/jgm.70026.

DOI:10.1002/jgm.70026
PMID:40474350
Abstract

Renal cell carcinoma (RCC) is a malignant neoplasm arising from the renal epithelium and constitutes approximately 2% of global cancer diagnoses and mortalities. With increasing prevalence, RCC remains a pressing clinical challenge, particularly because of its resistance to conventional therapies and poor outcomes in advanced stages. Long noncoding RNAs (lncRNAs) have been proposed as key molecular mediators in RCC, orchestrating critical pathways such as epithelial-to-mesenchymal transition (EMT), cellular proliferation, apoptosis, angiogenesis, and metastasis. Their roles in therapeutic resistance, including chemoresistance and radioresistance, further highlight their impact on treatment outcomes. Additionally, the potential of natural compounds such as curcumin, quercetin, and resveratrol to target lncRNA-mediated pathways has garnered attention, offering insights into novel therapeutic strategies. This review examines the biogenic pathways and multifaceted functions of lncRNAs, shedding light on their influence on RCC pathophysiology and posttranscriptional regulation. In addition, this review emphasizes the repercussions of natural compounds as lncRNA-targeted therapies, thus offering a comprehensive perspective on emerging strategies that may lead to more effective and personalized treatments.

摘要

肾细胞癌(RCC)是一种起源于肾上皮的恶性肿瘤,约占全球癌症诊断和死亡病例的2%。随着发病率的上升,RCC仍然是一个紧迫的临床挑战,特别是由于其对传统疗法的耐药性以及晚期预后不佳。长链非编码RNA(lncRNAs)被认为是RCC中的关键分子介质,协调上皮-间质转化(EMT)、细胞增殖、凋亡、血管生成和转移等关键途径。它们在治疗耐药性(包括化学耐药性和放射耐药性)中的作用,进一步凸显了它们对治疗结果的影响。此外,姜黄素、槲皮素和白藜芦醇等天然化合物靶向lncRNA介导途径的潜力已引起关注,为新的治疗策略提供了思路。本综述探讨了lncRNAs的生物合成途径和多方面功能,揭示了它们对RCC病理生理学和转录后调控的影响。此外,本综述强调了天然化合物作为lncRNA靶向疗法的影响,从而为可能导致更有效和个性化治疗的新兴策略提供了全面的视角。

相似文献

1
Natural Products and lncRNAs in Renal Cell Carcinoma: Emerging Therapeutic Approaches.肾细胞癌中的天然产物与长链非编码RNA:新兴治疗方法
J Gene Med. 2025 Jun;27(6):e70026. doi: 10.1002/jgm.70026.
2
CRNDE mediates the viability and epithelial-mesenchymal transition of renal cell carcinoma via miR-136-5p.CRNDE 通过 miR-136-5p 介导肾细胞癌的活力和上皮-间充质转化。
J Recept Signal Transduct Res. 2021 Jun;41(3):234-244. doi: 10.1080/10799893.2020.1805629. Epub 2020 Aug 18.
3
Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.长链非编码 RNA SNHG12 通过上调肾细胞癌中的 CDCA3 促进肿瘤进展和舒尼替尼耐药。
Cell Death Dis. 2020 Jul 8;11(7):515. doi: 10.1038/s41419-020-2713-8.
4
Long Noncoding RNA E2F1 Messenger RNA Stabilizing Factor (EMS) Promotes Sorafenib Resistance in Renal Cell Carcinoma by Regulating miR-363-3p and Dual-Specificity Phosphatase 10 Expression.长链非编码RNA E2F1信使核糖核酸稳定因子(EMS)通过调控miR-363-3p和双特异性磷酸酶10的表达促进肾细胞癌对索拉非尼的耐药性。
J Biochem Mol Toxicol. 2025 Mar;39(3):e70153. doi: 10.1002/jbt.70153.
5
High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition.长链非编码RNA HEIRCC的高表达通过诱导上皮-间质转化促进肾细胞癌转移。
Oncotarget. 2017 Jan 24;8(4):6555-6563. doi: 10.18632/oncotarget.14149.
6
Silencing of tumor-suppressive NR_023387 in renal cell carcinoma via promoter hypermethylation and HNF4A deficiency.通过启动子甲基化和 HNF4A 缺乏使肾细胞癌中的抑瘤基因 NR_023387 沉默。
J Cell Physiol. 2020 Mar;235(3):2113-2128. doi: 10.1002/jcp.29115. Epub 2019 Aug 20.
7
The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers.天然产物与 miRNA 在肾细胞癌中的作用:对疾病机制和诊断标志物的启示。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6417-6437. doi: 10.1007/s00210-024-03121-8. Epub 2024 May 1.
8
Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma.长链非编码RNA BX357664通过抑制肾细胞癌中的TGF-β1/p38/HSP27信号通路来调节细胞增殖和上皮-间质转化。
Oncotarget. 2016 Dec 6;7(49):81410-81422. doi: 10.18632/oncotarget.12937.
9
Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.长链非编码 RNA MALAT1 的耗竭通过调节 miR-362-3p 介导的 G3BP1 抑制肾细胞癌中的舒尼替尼耐药。
Cell Cycle. 2020 Aug;19(16):2054-2062. doi: 10.1080/15384101.2020.1792667. Epub 2020 Jul 14.
10
MATN1-AS1 Promotes Tumour Metastasis and Sunitinib Resistance via E2F2 in Clear Cell Renal Cell Carcinoma.MATN1-AS1通过E2F2促进透明细胞肾细胞癌的肿瘤转移和舒尼替尼耐药。
J Cell Mol Med. 2025 Feb;29(4):e70428. doi: 10.1111/jcmm.70428.

引用本文的文献

1
Long non-coding RNAs and signaling networks in non-small cell lung cancer: mechanistic insights into tumor pathogenesis.非小细胞肺癌中的长链非编码RNA与信号网络:对肿瘤发病机制的机制性见解
Cancer Gene Ther. 2025 Sep 15. doi: 10.1038/s41417-025-00950-4.
2
Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategies.肾细胞癌中微小RNA的靶向治疗:新兴治疗策略
Int J Clin Oncol. 2025 Aug 21. doi: 10.1007/s10147-025-02856-5.